Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIONEER: Atorvastatin and Pioglitazone in Carotid Atherosclerosis
NCT01341730Phase 4Terminated
- Sponsor
- The Catholic University of Korea
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in atherosclerosis, sponsored by The Catholic University of Korea. Started Jun 2011; status: terminated.
02
Drugs
pioglitazone
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01341730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341730.